1996 – 1999

Foundation of WaveLight Laser Technologie GmbH on April 30, 1996 in Erlangen by Max Reindl
First approvals for WaveLight products in Europe
Going public - IPO on „Neuer Markt“ in Frankfurt on September 15, 1999

2000 – 2005

Honored with the „Bayerischer Innovationspreis“ (Innovation Award of Bavaria)
FDA approval in the USA in 2003 for the ALLEGRETTO WAVE as first European laser manufacturer
Commissioning of state-of-the-art manufacturing- and production-plant in Pressath (Upper Palatinate)
WaveLight honored with the „red dot Design Award“ for the ophthalmological product line

Focus on the core competence refractive surgery
Disposal of the divisions urology, industrial lasers, aesthetics and intraocular surgery
Alcon, Inc. announces a voluntary public tender offer, published on August 10, 2007
Alcon, Inc. takes over sales, service and support for the refractive product range in the USA
Conclusion of a domination agreement on March 20, 2008 with the majority shareholder Alcon, Inc.
Registration of the domination agreement in the commercial register on March 3, 2009
Formal request by Alcon, Inc. on May 11, 2009 relative to the institution of a Squeeze-out procedure
CEO and company founder Max Reindl leaves the company on June 30, 2009
Wolfgang Tolle, former CEO of US subsidiary WaveLight, Inc., appointed new Chief Executive Officer, with effect as of
July 1, 2009
Squeeze out registered on October 12, 2009 in the commercial register, WaveLight belongs 100% to the Alcon-Group
October 21, 2009: Revokement of the admittance and delisting from German stock exchange

The WaveLight AG changed its corporate name by April, 15 2010 to WaveLight GmbH. The WaveLight GmbH is th legal successor of the WaveLight AG. The entry in the Commercial Register of the City of Fuerth was effected.